CDEK by Data4ThePeople
Sign in Sign up
← All organizations

Viewpoint Molecular Targeting

For profit

Also known as: Viewpoint Molecular Targeting

Phase 1Phase 2Phase 3Phase 4

First clinical trial

Mar 5, 2021

Last known activity

Mar 31, 2023

Acquired by IsoRay Medical, Inc. → Viewpoint Molecular Targeting → IsoRay Medical, Inc. → Viewpoint Molecular Targeting → IsoRay Medical, Inc. → Viewpoint Molecular Targeting → IsoRay Medical, Inc. → Viewpoint Molecular Targeting → IsoRay Medical, Inc. → Viewpoint Molecular Targeting → IsoRay Medical, Inc. → Viewpoint Molecular Targeting → IsoRay Medical, Inc. → Viewpoint Molecular Targeting → IsoRay Medical, Inc. → Viewpoint Molecular Targeting → IsoRay Medical, Inc. → Viewpoint Molecular Targeting → IsoRay Medical, Inc. → Viewpoint Molecular Targeting → IsoRay Medical, Inc. → Viewpoint Molecular Targeting → IsoRay Medical, Inc. → Viewpoint Molecular Targeting → IsoRay Medical, Inc. on Oct 18, 2022

Timeline

2000s

  1. Jun 1, 2008

    Viewpoint Molecular Targeting— Founded

2020s

  1. Oct 9, 2022

    IsoRay Medical, Inc.— Acquired

  2. Oct 18, 2022

    IsoRay Medical, Inc.— Acquired By

  3. Oct 18, 2022

    IsoRay Medical, Inc.— Now

Drugs by trial phase (6 distinct, 7 trials)

Phase 1 (0 own, 2 via acquisition)

Subsidiaries (1 direct, 25 total across the full acquisition tree)

Recent trials (5)

Details

Founded
Iowa City, IA, US Jun 1, 2008
Last known activity
Mar 31, 2023